tradingkey.logo
tradingkey.logo
Search

Bolt Biotherapeutics Inc

BOLT
Add to Watchlist
3.990USD
+0.100+2.57%
Close 07-31 16:00ETQuotes delayed by 15 min
7.66MMarket Cap
LossP/E TTM

BOLT Financials

See Bolt Biotherapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bolt Biotherapeutics Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-4.31/-2.85
Revenue / Forecast
26.00K/1.50M
Period
FY2025 Earnings
Revenue(YoY)
7.70M
0.07%
EPS(YoY)
-17.85
46.01%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
25.15%-4.31
53.84%-3.84
53.09%-3.72
59.84%-4.46
-1.39%-5.76
11.79%-8.32
7.58%-7.94
-16.21%-11.12
36.97%-5.68
11.39%-9.44
---8.59
---9.57
---9.01
---10.65
---1.83
----
----
----
----
----
Revenue
-97.87%26.00K
--2.50M
90.10%2.17M
41.49%1.80M
-76.83%1.22M
-100.00%0.00
-54.87%1.14M
-11.03%1.27M
188.83%5.27M
48.05%2.09M
19.70%2.53M
2.87%1.43M
124.60%1.83M
177.76%1.41M
180.85%2.11M
--1.39M
--813.00K
--508.00K
--752.00K
-100.00%0.00
Net Profit
34.38%-7.24M
58.39%-6.63M
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.20M
36.33%-10.81M
10.47%-17.90M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
26.37%-20.00M
6.99%-21.76M
3.91%-22.66M
3.17%-23.68M
12.50%-27.16M
-133.93%-23.39M
-113.27%-23.59M
Net Margin
-2983.95%-27861.54%
---265.24%
75.24%-329.37%
71.45%-474.56%
-340.73%-903.44%
----
-106.83%-1330.06%
-31.92%-1662.35%
77.96%-204.99%
39.53%-857.01%
---643.08%
---1260.08%
---929.90%
---1417.22%
---1577.14%
----
----
----
----
----
Gross Margin
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Revenue
-97.87%26.00K
--2.50M
90.10%2.17M
41.49%1.80M
-76.83%1.22M
-100.00%0.00
-54.87%1.14M
-11.03%1.27M
188.83%5.27M
48.05%2.09M
19.70%2.53M
2.87%1.43M
124.60%1.83M
177.76%1.41M
180.85%2.11M
--1.39M
--813.00K
--508.00K
--752.00K
-100.00%0.00
Operating profit
37.26%-7.60M
64.23%-5.61M
53.15%-7.70M
51.61%-9.21M
29.12%-12.12M
20.73%-15.67M
9.57%-16.44M
4.03%-19.03M
7.18%-17.09M
6.06%-19.77M
18.63%-18.18M
13.99%-19.83M
22.87%-18.41M
22.29%-21.04M
5.02%-22.35M
2.95%-23.06M
-29.58%-23.88M
-60.00%-27.07M
-89.65%-23.53M
-113.87%-23.76M
Net Profit
34.38%-7.24M
58.39%-6.63M
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.20M
36.33%-10.81M
10.47%-17.90M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
26.37%-20.00M
6.99%-21.76M
3.91%-22.66M
3.17%-23.68M
12.50%-27.16M
-133.93%-23.39M
-113.27%-23.59M
Current assets
-39.42%25.75M
-40.45%30.26M
-37.69%35.61M
-49.97%38.34M
-55.28%42.51M
-51.93%50.81M
-54.45%57.15M
-41.35%76.63M
-27.77%95.06M
-38.81%105.71M
-28.23%125.47M
-27.91%130.67M
-32.88%131.61M
-8.68%172.75M
-21.42%174.83M
-26.95%181.26M
-27.70%196.09M
645.87%189.16M
460.71%222.49M
354.26%248.15M
Total current liabilities
-45.86%7.34M
-46.80%8.44M
-44.89%9.97M
-31.23%12.31M
-18.90%13.56M
-22.49%15.86M
-3.56%18.08M
1.60%17.90M
2.89%16.72M
-11.51%20.46M
-22.43%18.75M
-5.39%17.62M
-15.81%16.25M
8.39%23.12M
2.02%24.17M
-3.26%18.62M
60.72%19.31M
89.35%21.33M
139.25%23.70M
142.20%19.25M
Total assets
-44.06%48.03M
-43.04%56.75M
-40.50%65.05M
-39.20%75.50M
-39.91%85.86M
-37.65%99.63M
-37.65%109.33M
-34.88%124.18M
-30.70%142.89M
-29.86%159.78M
-28.57%175.35M
-26.72%190.70M
-27.09%206.18M
-25.97%227.81M
-26.40%245.50M
-25.02%260.24M
-12.89%282.79M
561.16%307.72M
440.28%333.55M
409.35%347.07M
Total liabilities
-27.78%28.20M
-28.73%30.24M
-11.66%32.95M
-4.33%36.66M
0.82%39.05M
-9.80%42.43M
-20.79%37.30M
-21.10%38.32M
-20.13%38.73M
-16.44%47.04M
-17.46%47.10M
-7.09%48.56M
-10.85%48.49M
-2.25%56.30M
-2.69%57.06M
2.13%52.27M
154.33%54.40M
24.69%57.60M
88.99%58.64M
83.92%51.18M
Total equity
-57.65%19.82M
-53.66%26.50M
-55.43%32.10M
-54.76%38.84M
-55.06%46.81M
-49.27%57.20M
-43.84%72.03M
-39.59%85.86M
-33.95%104.16M
-34.26%112.74M
-31.94%128.26M
-31.66%142.13M
-30.96%157.69M
-31.43%171.51M
-31.45%188.45M
-29.72%207.97M
-24.68%228.39M
71567.34%250.12M
795.19%274.91M
633.96%295.90M
Net operating income
39.97%-8.02M
50.41%-7.16M
30.32%-9.73M
40.55%-9.60M
20.21%-13.37M
-1.16%-14.43M
16.62%-13.97M
-6.82%-16.14M
28.41%-16.75M
20.54%-14.27M
-24.52%-16.75M
27.30%-15.11M
3.76%-23.40M
-0.89%-17.95M
28.17%-13.45M
-421.50%-20.79M
-46.83%-24.31M
-38.04%-17.79M
-49.64%-18.73M
67.50%-3.99M
Net investment
-45.55%7.92M
-91.22%1.07M
4.35%17.88M
-40.05%10.79M
42.61%14.55M
-22.63%12.23M
35.39%17.14M
32.57%18.00M
-64.81%10.20M
-3.81%15.81M
772.97%12.66M
1664.52%13.58M
-29.02%28.99M
-21.86%16.43M
109.00%1.45M
98.14%-868.00K
121.44%40.84M
1134.33%21.03M
-23.03%-16.11M
-1157.45%-46.60M
Net financing
--6.00K
-82.76%5.00K
--0.00
-82.28%14.00K
--0.00
-72.64%29.00K
--0.00
-46.26%79.00K
----
-26.39%106.00K
--0.00
-41.67%147.00K
-100.00%0.00
-70.91%144.00K
-100.00%0.00
-98.12%252.00K
-99.96%107.00K
146.48%495.00K
120.04%185.00K
-67.73%13.41M

FAQs

What is the total revenue of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its total revenue reached 7.70M, with a year-on-year change of 7.69M.

What are the current assets of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its current assets were 30.26M, with a year-on-year change of -40.45.

What are the total assets of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its total assets of Bolt Biotherapeutics Inc were 56.75M, with a year-on-year change of -43.04.

What are the total liabilities of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its total liabilities of Bolt Biotherapeutics Inc were 30.24M, with a year-on-year change of -28.73.

What is the total equity of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its total equity of Bolt Biotherapeutics Inc was 26.50M, with a year-on-year change of -53.66.

What is the net operating income of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its net operating income of Bolt Biotherapeutics Inc was -34.63M, with a year-on-year change of 49.25.

What is the net investment of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its net investment of Bolt Biotherapeutics Inc was 44.30M, with a year-on-year change of -23.05.

What is the net financing of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its net financing of Bolt Biotherapeutics Inc was 19.00K, with a year-on-year change of -82.41.

What is the Earnings Per Share (EPS) of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -17.85, with a year-on-year change of 46.01.

What is the net income of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its net income was -33.38M, with a year-on-year change of 47.12.

What is the net margin of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its net profit margin was -433.74, with a year-on-year change of 47.16.

What is the Return on Equity (ROE) of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -79.75, with a year-on-year change of -7.36.

What is the Return on Assets (ROA) of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.69, with a year-on-year change of 12.28.

What is the operating profit of Bolt Biotherapeutics Inc?

According to Bolt Biotherapeutics Inc's FY2025 earnings report, its operating profit was -34.63M, with a year-on-year change of 49.25.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.